Literature DB >> 32159884

Clinical correlates in children with autism spectrum disorder and CNVs: Systematic investigation in a clinical setting.

Rita Barone1,2, Mariangela Gulisano1, Renata Amore1, Carla Domini1, Maria Chiara Milana1, Sabrina Giglio3, Francesca Madia4, Teresa Mattina5, Antonino Casabona6, Marco Fichera5,7, Renata Rizzo1.   

Abstract

Autism spectrum disorder (ASD) is associated with various molecular mechanisms including copy number variants (CNVs). We investigated possible associations between CNVs and ASD clinical correlates. We evaluated pertinent physical characteristics and phenotypic measures such as cognitive level, severity of ASD symptoms and comorbid conditions in ASD patients consecutively recruited over the study period. Children with causative (C-CNVs), non-causative (NC-CNVs) and without CNVs (W-CNVs) were compared. Out of 109 patients, 31 imbalances (16 duplications and 15 deletions) were detected in 25 subjects. Seven (6.4%) had C-CNVs and 18 (16.5%) had NC-CNVs. Paired post hoc comparisons with Bonferroni adjustment showed that dysmorphisms and microcephaly were significantly more frequent in the C-CNVs group. Patients with C-CNVs had more severe autistic core symptoms, while comorbid internalizing behavioral symptoms were more represented among participants with NC-CNVs. No significant differences were observed for distribution of macrocephaly, intellectual disability, epilepsy, isolated electroencephalogram abnormalities and studied neuroimaging characteristics among groups. Recurrent and rare C-CNVs highlighting genes relevant to neurodevelopment had a statistically higher occurrence in children with more severe ASD symptoms and further developmental abnormalities. This study documents the importance of measuring the physical and neurobehavioural correlates of ASD phenotypes to unravel the underlying molecular mechanisms in patient subgroups.
© 2020 International Society for Developmental Neuroscience.

Entities:  

Keywords:  CNV; autism severity; autism spectrum disorder; dysmorphism; microcephaly

Year:  2020        PMID: 32159884     DOI: 10.1002/jdn.10024

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  2 in total

1.  Towards a Change in the Diagnostic Algorithm of Autism Spectrum Disorders: Evidence Supporting Whole Exome Sequencing as a First-Tier Test.

Authors:  Ana Arteche-López; Maria José Gómez Rodríguez; Maria Teresa Sánchez Calvin; Juan Francisco Quesada-Espinosa; Jose Miguel Lezana Rosales; Carmen Palma Milla; Irene Gómez-Manjón; Irene Hidalgo Mayoral; Rubén Pérez de la Fuente; Arancha Díaz de Bustamante; María Teresa Darnaude; Belén Gil-Fournier; Soraya Ramiro León; Patricia Ramos Gómez; Olalla Sierra Tomillo; Alexandra Juárez Rufián; Maria Isabel Arranz Cano; Rebeca Villares Alonso; Pablo Morales-Pérez; Alejandro Segura-Tudela; Ana Camacho; Noemí Nuñez; Rogelio Simón; Marta Moreno-García; Maria Isabel Alvarez-Mora
Journal:  Genes (Basel)       Date:  2021-04-12       Impact factor: 4.096

2.  Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder.

Authors:  Behrang Mahjani; Silvia De Rubeis; Christina Gustavsson Mahjani; Maureen Mulhern; Xinyi Xu; Lambertus Klei; F Kyle Satterstrom; Jack Fu; Michael E Talkowski; Abraham Reichenberg; Sven Sandin; Christina M Hultman; Dorothy E Grice; Kathryn Roeder; Bernie Devlin; Joseph D Buxbaum
Journal:  Mol Autism       Date:  2021-10-06       Impact factor: 6.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.